Acris GmbH was founded 1998 as a spinoff of DPC Biermann GmbH, the German subsidiary of Diagnostic Products Corp., Los Angeles. Acris took over responsibility for marketing the DPC Biermann research products. From 1999 to 2003 Acris GmbH focused more and more on the research antibodies.

The first Antibody Catalog was released 1999 and the number of antibodies increased from several hundred in 1998 to more than 175,000 in 2011. In the beginning Acris GmbH served as a distributor for US and UK antibody manufacturers in the German market. In September 2003 Acris GmbH became a fully independent company and took over all research products and customers from DPC. Acris GmbH was renamed Acris Antibodies GmbH what should better reflect our business.

From the very beginning it was our mission to serve the research community with high quality research products. It was our idea to resolve a problem what nearly any researcher is confronted with: “How can I find a product/antibody which will work optimal in my research application”. To help these scientists we used the strategy to develop a platform for thousands of high quality antibodies in one easy to search online database. In the final stage we achieved in 2010 we were able to offer more than 170,000 primary antibodies partly sold as Acris own products partly offered as distributed products from all over the world. As complementary products we added more than 50,000 proteins, lysates and kits.

During the years Acris Antibodies developed from a German distributor to a global player in the research product antibody market. Distributors in Europe and Asia were added and in the beginning of 2011 we opened a branch office in San Diego, USA.

Since November 2012, Acris Antibodies GmbH is DIN EN ISO 9001 certified. We have implemented and certified our Quality Management to show our dedication towards our goal: We aim to satisfy our customers with outstanding service and high quality products. Learn more about our quality policy here.

In the next couple of years we will strengthen our international position by adding new and innovative products to our portfolio as well as by introducing custom services for antibody and peptide production and antibody validation.